Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Market Cap

Anika Therapeutics has a market cap or net worth of $214.20 million as of March 28, 2025. Its market cap has decreased by -43.27% in one year.

• Market Cap: 214.20M
• Enterprise Value: 190.03M
• 1-Year Change: -43.27%
• Ranking: #3560
• Category: Micro-Cap
• Stock Price: $15.11

Market Cap Chart

Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $214.20M, an increase of 318.36%. That is a compound annual growth rate of 5.58%.

Market Cap History

Date	Market Cap	% Change
Mar 27, 2025	219.70M	-8.88%
Dec 31, 2024	241.10M	-27.34%
Dec 29, 2023	331.80M	-23.27%
Dec 30, 2022	432.40M	-16.41%
Dec 31, 2021	517.30M	-19.59%
Dec 31, 2020	643.30M	-13.06%
Dec 31, 2019	739.90M	54.92%
Dec 31, 2018	477.60M	-39.57%
Dec 29, 2017	790.40M	10.39%
Dec 30, 2016	716.00M	28.18%
Dec 31, 2015	558.60M	-5.47%
Dec 31, 2014	590.90M	12.00%
Dec 31, 2013	527.60M	284.27%
Dec 31, 2012	137.30M	2.85%
Dec 30, 2011	133.50M	48.50%
Dec 31, 2010	89.90M	2.98%
Dec 31, 2009	87.30M	152.31%
Dec 31, 2008	34.60M	-78.71%
Dec 31, 2007	162.50M	14.12%
Dec 29, 2006	142.40M	16.06%
Dec 30, 2005	122.70M	31.51%
Dec 31, 2004	93.30M	-4.11%
Dec 31, 2003	97.30M	892.86%
Dec 31, 2002	9.80M	-1.01%
Dec 31, 2001	9.90M	26.92%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	740.24B
UnitedHealth Group	475.14B
Johnson & Johnson	395.22B
AbbVie	361.76B
Novo Nordisk	308.71B
Abbott Laboratories	228.01B
Merck & Co.	225.93B
AstraZeneca	225.00B